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           Upon T cell activation, naive CD4  +   T cells can 
diff  erentiate into distinct cell lineages, including 
the classical Th1 and Th2 cells (  1, 2  ), as well as 
the recently defi  ned Th cells producing IL-17 
(Th17 cells) (  3  ) and inducible Treg (iTreg) cells 
(  4  ). These cells play important roles in adaptive 
immunity (  5  ). Th1 cells mainly produce IFN-     
and are involved in immunity against intracellu-
lar pathogens. Th2 cells produce IL-4, IL-5, and 
IL-13, are involved in immunity against hel-
minths and other extracellular parasites, and en-
hance antibody responses. Th17 cells produce 
IL-17a, IL-17f, IL-21, and IL-22, and are critical 
for immunity against extracellular bacteria and 
fungi. Th1, Th2, and Th17 cells are also involved 
in the induction or maintenance of autoimmune 
and immunopathologic diseases. Thus, Th1 and 
Th17 cells are linked to many organ-specifi  c 
autoimmune diseases, and Th2 cells play critical 
roles in asthma and other allergic diseases. iTreg 
cells, functionally similar to naturally occurring 
Treg cells (  6  ), can regulate immune responses. 
Among naturally occurring Treg cells, a subset 
expressing CD103 has been reported to contain 
the highest suppressive activity and to be present 
in the mucosal tissues, such as in the gut, as well 
as at sites of infl  ammation (  7, 8  ). Interestingly, a 
large number of CD4 cells diff  erentiated in the 
presence of TGF-     in vitro express CD103 (  9  ), 
and TGF-     has been shown to induce Treg cell 
diff  erentiation (  4  ). 
  The cytokine milieu during CD4 T cell ac-
tivation is one of the most important factors in 
determining T cell fate. IL-12 and IFN-     induce 
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  Growth factor independent 1 (Gfi  -1), a transcriptional repressor, is transiently induced during 
T cell activation. Interleukin (IL) 4 further induces Gfi  -1, resulting in optimal Th2 cell expan-
sion. We report a second important function of Gfi  -1 in CD4 T cells: prevention of alternative 
differentiation by Th2 cells, and inhibition of differentiation of naive CD4 T cells to either 
Th17 or inducible regulatory T (iTreg) cells. In   Gfi  1      /        Th2 cells, the   Rorc  ,   Il23r  , and   Cd103   
loci showed histone 3 lysine 4 trimethylation modifi  cations that were lacking in wild-type Th2 
cells, implying that Gfi  -1 is critical for epigenetic regulation of Th17 and iTreg cell  –  related 
genes in Th2 cells. Enforced Gfi  -1 expression inhibited IL-17 production and iTreg cell differ-
entiation. Furthermore, a key inducer of both Th17 and iTreg cell differentiation, transform-
ing growth factor     , repressed Gfi  -1 expression, implying a reciprocal negative regulation of 
CD4 T cell fate determination. Chromatin immunoprecipitation showed direct binding of the 
Gfi  -1  –  lysine-specifi  c demethylase 1 repressive complex to the intergenic region of   Il17a/Il17f   
loci and to intron 1 of   Cd103  . T cell  –  specifi  c   Gfi  1   conditional knockout mice displayed a 
striking delay in the onset of experimental allergic encephalitis correlated with a dramatic 
increase of Foxp3  +  CD103  +   CD4 T cells. Thus, Gfi  -1 plays a critical role both in enhancing Th2 
cell expansion and in repressing induction of Th17 and CD103  +   iTreg cells. 
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some IFN-    , suggesting that Gfi  -1 is important for sustain-
ing the Th2 cell phenotype. A recent report suggests that 
Gfi  -1, as a transcriptional repressor, is associated with the 
histone lysine-specifi  c demethylase 1 (LSD1), which results 
in demethylation of histone 3 lysine 4 (H3K4) at target pro-
moters (  46  ). LSD1 demethylates mono- and dimethylation 
but not trimethylation of H3K4. However, because of the 
balance of diff  erent methylation states, active gene promoter 
regions usually contain higher levels of H3K4 trimethyl-
ation than of mono- and dimethylation (  47  ). To search for 
Gfi  -1 target genes in T cells, the chromatin immunoprecip-
itation (ChIP)  –  Seq technology was applied. We used H3K4 
trimethylation, the end product of H3K4 methylation, as an 
indicator, reasoning that such modifi  cation would not ac-
cumulate in   Gfi  1      /        cells at Gfi  -1 target sites because of a 
lack of the mono- or dimethylated forms of H3K4. As ex-
pected, both wild-type and   Gfi  1   cKO Th2 cells displayed a 
similar pattern of H3K4 trimethylation at the   Gata3   locus 
(  Fig. 1 A  ).   Because H3K4 methylation is associated with active 
chromatin, this indicates that Gfi  -1, although important for 
Th2 expansion, is not essential for the Th2 polarization 
process. Interestingly, at the   Cd103   locus, whose expression 
is associated with a subset of Treg cells,   Gfi  1   cKO Th2 cells 
showed high levels of H3K4 modifi  cation that was absent in 
wild-type Th2 or Th17 cells (  Fig. 1 B  ). At the   Rorc   locus, 
which encodes ROR    t, critical for Th17 cell diff  erentia-
tion,   Gfi  1   cKO Th2 cells displayed levels of H3K4 modifi  -
cation similar to Th17 cells (  Fig. 1 C  ). H3K4 modifi  cation 
was also detected at the   Il23r   locus in   Gfi  1   cKO Th2 cells 
(  Fig. 1 D  ). Such a modifi  cation was absent in wild-type 
Th2 cells.   Gfi  1   cKO Th2 cells did not appear to be con-
taminated with Th17 cells, because H3K4 trimethylation at 
the   Il21   and   Il17f   loci was not observed the   Gfi  1   cKO Th2 
cells, although it was prominent in Th17 cells (  Fig. 1, E and F  ). 
These results indicate that Gfi  -1 plays an important role 
in chromatin remodeling of Th17 and iTreg cell  –  related 
genes, including   Rorc, Il23r  , and   Cd103  , in Th2 cells. Al-
though   Gfi  1   cKO Th2 cells displayed an active   Rorc   locus, 
expression of ROR    t in   Gfi  1   cKO Th2 cells is much 
lower than that in Th17 cells (unpublished data), indicating 
that additional factors, possibly induced by TGF-     and IL-6, 
are required for   Rorc   expression as well as for the induction 
of IL-17. 
  Expression of Gfi  -1 induced by IL-4 inhibits 
IL-17 production 
  To test the signifi  cance of the chromatin modifi  cation change 
at the   Rorc   locus, wild-type or   Gfi1   cKO CD4 T cells 
were primed under Th2 conditions for one round, and cells 
were then either restimulated under Th2 conditions or 
switched to Th17 priming conditions.   Gfi  1   cKO Th2 cells 
expanded less well than wild-type Th2 cells, as previously 
reported (  41  ); the expansion defect of   Gfi  1   cKO Th2 cells 
was smaller when they were cultured under Th17 condi-
tions (  Fig. 2 A  ).   In the wild-type group, 24.5% of the cells 
from the culture restimulated under Th2 conditions 
Th1 cell diff  erentiation (  10  –  12  ); IL-4 and IL-2 induce Th2 
cell diff  erentiation (  13  –  16  ), TGF-     and IL-6/IL-21 induce 
Th17 cell differentiation (  17  –  19  ), and TGF-     and IL-2 
induce iTreg cell generation (  4, 20  ). Although several tran-
scription factors are involved in the diff  erentiation and main-
tenance of each Th cell type, Th cell diff  erentiation is mainly 
controlled by specifi  c master transcription factors and Stat 
family members: T-bet and Stat4 for Th1 cells (  21  –  23  ), 
GATA-3 and Stat5 for Th2 cells (  14, 24  –  27  ), ROR    t and 
Stat3 for Th17 cells (  28, 29  ), and Foxp3 and Stat5 for Treg 
cells (  4, 20, 30, 31  ). 
  Growth factor independent 1 (Gfi  -1), a transcriptional 
repressor, was initially reported as a protooncogene that 
allows an IL-2  –  dependent cell line to be IL-2 independent 
(  32  ). Gfi  -1 was also found as a common insertion site in 
Moloney murine leukemia virus –  induced T lymphomas ( 33, 34 ). 
During Th2 cell diff  erentiation, the expression levels of 
GATA-3 are enhanced as a result of TCR-mediated signal-
ing and/or activation of the IL-4  –  Stat6 pathway (  35, 36  ). 
In collaboration with Stat5, activated by IL-2, GATA-3 in-
duces remodeling of the   Il4   locus and the capacity to pro-
duce IL-4 when cells are stimulated through TCRs. Gfi  -1 is 
transiently induced by TCR stimulation (  37, 38  ). Its expres-
sion is further enhanced and prolonged by IL-4, resulting in 
optimal Th2 cell proliferation (  37  ). Gfi  -1 selects GATA-3  hi   
cells to grow in IL-2, suggesting that there is a selective 
component involving Gfi  -1 in Th2 cell diff  erentiation (  37  ). 
  Three groups, including ours, have generated germline 
  Gfi  1   KO mice (  39  –  41  ). Many abnormalities have been ob-
served, including neutropenia (  39, 40  ), a T cell development 
defect (  41, 42  ), a hematopoietic stem cell defect (  43, 44  ), and 
defects in dendritic cell development and function (  45  ). The 
profound defect in T cell development in   Gfi  1      /        mice is as-
sociated with a large proportion of their peripheral CD4 T cells 
displaying memory-like phenotypes (  40  ), presumably as a result 
of lymphopenia-driven cell proliferation and diff  erentiation. 
  To analyze the role played by Gfi  -1 in the diff  erentiation 
and/or growth of normal CD4 T cells, we generated   Gfi  1   
conditional KO (  Gfi  1   cKO) mice (  41  ) in which Gfi  -1 is de-
leted only in T cells. Th2 cells diff  erentiated from   Gfi  1   cKO 
mice have a severe defect in cell expansion. In vivo, the Th2 
response is dramatically impaired in these KO mice. On the 
other hand, IFN-     production is enhanced in the absence of 
Gfi  -1, raising the possibility that Gfi  -1 may negatively regu-
late the diff  erentiation of other Th cell lineages. We report 
that Gfi  -1 suppresses both Th17 and CD103  +   iTreg cell dif-
ferentiation, whereas TGF-    , critical for Th17 and iTreg cell 
induction, down-regulates Gfi  -1 expression. In the absence of 
Gfi  -1, Foxp3    +    CD103    +     Treg cells are preferentially expanded 
in vivo upon immunization. 
    RESULTS   
  Th2 cells lacking   Gfi  1   display an active genomic 
confi  guration at the   Cd103  ,   Rorc  , and   Il23r   loci 
  Th2 cells diff  erentiated from   Gfi  1   cKO (  Gfi  1  fl / fl     -CD4Cre) 
mice have a severe defect in cell expansion and also produce JEM VOL. 206, February 16, 2009 
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  To exclude the possibility that the induction of IL-17 in 
  Gfi  1   cKO cells is from a small fraction of non  –  Th2 cells, we 
bred our   Gfi  1   cKO mice to heterozygous G4 mice, in which 
one   Il4   allele was replaced by   eGfp   (  48  ). After one round of 
Th2 priming, GFP  +   cells (Th2 cells) were sorted and re-
stimulated under Th2 or Th17 conditions. Similar to the 
results shown in the previous paragraph, 6.5% of the GFP  +   
cells from the   Gfi  1   cKO group were able to produce IL-17 
after reculturing under Th17 conditions. Again, the eff  ect of 
  Gfi  1   in cell expansion under Th17 culture conditions was 
minimal (  Fig. 2 B  ). 
  IL-4 has been reported to suppress the induction of IL-17 
production (  49, 50  ). The detailed mechanism is not clear. To 
produced IL-4, whereas, only 8% of the cells that were 
switched from Th2 to Th17 conditions produced IL-4, im-
plying that TGF-     suppresses IL-4 production in diff  erenti-
ated Th2 cells ( Fig. 2 A ). Nevertheless, neither cell population 
was capable of producing IL-17, suggesting that TGF-     
and/or IL-6 is not eff  ective in inducing IL-17 production in 
diff  erentiated Th2 cells. In contrast, in the   Gfi  1   cKO group, 
although IL-4 production was also reduced (from 16.3 to 
5.6%) when cells were switched from Th2 to Th17 condi-
tions, 8.2% of the switched cells were capable of making IL-17. 
These data indicate that Gfi  -1 expression in Th2 cells, in-
duced by IL-4, prevents the induction of IL-17 by TGF-     
and IL-6. 
    Figure 1.         Abnormal histone H3K4 trimethylation at the   Cd103  ,   Rorc  , and   Il23r   loci in   Gfi  1   cKO Th2 cells.   CD4 +   T cells from naive wild-type or 
  Gfi  1   cKO mice were activated under Th2 or Th17 conditions for 4 d. Cells were harvested and fi  xed. ChIP-Seq analysis was performed using a specifi  c 
antibody against H3K4 trimethylation (H3K4me3). The sequence tags mapped to the locus of (A)   Gata3  , (B)   Cd103  , (C)   Rorc  , (D)   Il23r  , (E)   Il21  , and (F)   Il17f  
are shown. The total tag numbers mapped to the genome are 2, 6, and 7.1 million for WT-Th17,   Gfi  1   cKO  –  Th2, and WT-Th2, respectively. The scale for the 
WT-Th17 sample was adjusted separately because of approximately threefold fewer total tag numbers.     332 RECIPROCAL REGULATIONS BETWEEN GFI-1 AND TGF-       | Zhu et al. 
  Gfi  -1 expression is down-regulated by TGF-     
  Because Gfi-1, induced by IL-4, has an effect on both 
ROR    t and IL-17, we tested the normal expression levels 
of Gfi  -1 during Th17 cell diff  erentiation. Gfi  -1 expression 
was assessed by quantitative PCR after naive CD4 T cells 
were primed under Th1, Th2, Th17, and iTreg cell condi-
tions for 4 d. As expected, cells primed under diff  erent con-
ditions specifi  cally expressed their hallmark genes (IFN-     
for Th1 cells, IL-4 for Th2 cells, IL-17a for Th17 cells, and 
Foxp3 for iTreg cells;   Fig. 3 A  ).   Th2 cells expressed approx-
imately twice as much Gfi  -1 as Th1 cells, as previously re-
ported (  37  ). Th17 and iTreg cells expressed very low levels 
of Gfi  -1. To test when the diff  erence in Gfi  -1 expression 
test whether Gfi  -1 mediates the suppression of IL-17 by IL-4, 
we performed a Th17 to Th2 switching experiment. In-
deed, IL-4 suppressed IL-17 production (from 3.7 to 0.5%) 
and induced IL-4 production (from 0.1 to 6.4%) in wild-type 
cells (  Fig. 2 C  ), but IL-4 failed to suppress IL-17 production 
in   Gfi  1   cKO cells even though it still induced its own pro-
duction.   Gfi  1   cKO cells showed an approximately twofold 
decrease in cell expansion, compared with wild-type cells, 
when switched from Th17 to Th2 conditions. Strikingly,     1% 
of the cells can produce both IL-17 and IL-4 when   Gfi  1   cKO 
Th17 cells were switched to Th2 conditions, suggesting that 
Gfi  -1 plays an important role in IL-4  –  mediated suppression 
of IL-17 production. 
    Figure 2.         Endogenous Gfi  -1 induced by IL-4 suppresses IL-17 production.   (A and B) CD4  +   T cells from naive mice were activated under Th2 condi-
tions for 4 d. After 2 d, cultured in complete RPMI 1640 with IL-2, cells were either (A) unsorted or (B) sorted for GFP  +   (IL-4 – producing)  cells  and  were 
further stimulated under Th2 or Th17 conditions for another 4 d. (C) CD4  +   T cells were fi  rst activated under Th17 conditions before they were stimulated 
under Th2 or Th17 conditions for the second round. Cells were counted before and after the second round of stimulation. Fold cell expansion was calcu-
lated. Cytokine production was assessed by intracellular staining after PMA plus ionomycin stimulation. Numbers indicate the percentage of cells in each 
quadrant or gate. Error bars represent means   ±   SD, and data are representative of two independent experiments.     JEM VOL. 206, February 16, 2009 
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pression levels of Bcl-2 and Bim. The suppression of Gfi  -1 
expression by TGF-     may explain the low levels of Gfi  -1 
expression in cells that have undergone Th17 and iTreg cell 
diff  erentiation. 
  Expression of Gfi  -1 inhibits IL-17 production but not 
induction of ROR    t in cells primed with TGF-     plus IL-6 
  To test the importance of Gfi  -1 down-regulation by TGF-    , 
Gfi  -1 was introduced by retroviral infection into activated 
CD4 T cells primed under Th17 conditions. 4 d after infec-
tion, IL-17 production was assessed upon restimulation with 
PMA plus ionomycin. A similar proportion of the cells in-
fected by control GFP  –  retroviral vector (RV) and uninfected 
cells, in the same culture, produced IL-17 (17.8 vs. 15%; 
  Fig. 4 A  , left).   However, only 3.9% of the cells infected by 
the Gfi  -1  –  GFP-RV, compared with 14.1% of the uninfected 
cells in the same culture, produced IL-17. Three indepen-
dent experiments showed signifi   cant suppression of IL-17 
production by Gfi  -1 (  Fig. 4 A  , right). 
  Because ROR    t has been reported to be the master reg-
ulator for Th17 cells and TGF-     plus IL-6 are required for 
Th17 cell diff  erentiation (  17  –  19, 28  ), we tested the expres-
sion of ROR    t, TGF-    Rs, and IL-6R     among Th1, Th2, 
and Th17 cells. ROR    t was selectively expressed in Th17 
cells, consistent with previous reports (Fig. S1 A, available at 
http://www.jem.org/cgi/content/full/jem.20081666/DC1). 
Interestingly, both TGF-    RI and TGF-    RII were expressed 
at higher levels in Th17 cells than in Th1 and Th2 cells. IL-
6R     was also found to be highest in Th17 cells (Fig. S1 A). 
3 d after infection with Gfi  -1  –  GFP-RV, although expression 
of ROR    t, TGF-    RI, and TGF-    RII in infected cells was 
not aff  ected (  Fig. 4 B   and Fig. S1 B), expression of IL-6R     
was suppressed (Fig. S1 B). Consistent with the intracellular 
staining results shown in   Fig. 4 A  , both IL-17a and IL-17f 
mRNA levels were reduced by enforced expression of Gfi  -1 
(  Fig. 4 B  ). Enforced Gfi  -1 expression in   Gfi  1   cKO Th17 cells 
also suppressed IL-17a but not ROR    t expression (Fig. S2). 
Suppression of IL-17 requires the Gfi  -1 suppressive domain, 
because Gfi  -1 bearing a single mutation in this domain (Gfi  -1 
(P2A)) failed to suppress IL-17 production (  Fig. 4 C  ). 
  The failure of Gfi  -1 to suppress ROR    t transcription in 
this setting is apparently at odds with the genomic data shown 
in   Fig. 1  , in which the   Rorc   locus is not H3K4 trimethylated in 
wild-type Th2 cells but is trimethylated in   Gfi  1   cKO Th2 cells. 
However, this discrepancy may be explained by the fact that 
retroviral-mediated expression of Gfi  -1 does not occur until 
24  –  48 h after infection, whereas ROR    t up-regulation by 
TGF-     occurred within 24 h (unpublished data). Alternatively, 
Gfi  -1 may require another Th2 factor as a cosuppressor of 
ROR    t transcription. Nevertheless, the data indicate that Gfi  -1 
suppresses IL-17 even when ROR    t is normally expressed. 
  To test the direct binding of Gfi  -1 to its putative target 
genes, ChIP using anti  –  Gfi  -1 antibody was performed. The 
Gfi  -1 DNA binding sites contain AATC, and sequences con-
taining AAATCNNNG are represented at the highest fre-
quency in a random oligonucleotide selection assay, suggesting 
occurred during the diff  erentiation process, cells were har-
vested at various time points after priming under diff  erent 
conditions. As early as 24 h after stimulation, Gfi  -1 was strik-
ingly underexpressed in cells primed under Th17 and iTreg 
cell conditions (  Fig. 3 B  ). 
  IL-4 rapidly induces Gfi  -1 expression in activated but 
not in naive CD4 T cells. As reported earlier (  37  ), cells 
previously activated in the presence of anti  –  IL-4 for 24 h 
expressed Gfi  -1 mRNA in response to IL-4 stimulation 
within 2 h (  Fig. 3 C  ). In the presence of TGF-    , IL-4 failed 
to up-regulate Gfi  -1. In addition, treatment with TGF-     
suppressed the basal level of Gfi  -1 expression, suggesting 
that TGF-     is directly involved in suppressing Gfi  -1 ex-
pression. In contrast, TGF-     did not block the induction of 
suppressor of cytokine signaling 1 by IL-4, suggesting the 
specifi  city of Gfi  -1 down-regulation by TGF-    . It did not 
appear that the TGF-     treatment mediated its eff  ects by 
increasing cell death. No major diff  erences in cell yields 
were observed, and there were no dif  ferences in the ex-
    Figure 3.         Gfi  -1 expression is down-regulated by TGF-    .   CD4 +   T 
cells from naive mice were activated under Th1, Th2, Th17, or iTreg con-
ditions for (A) 4 d or (B) 24 h, or (C) under ThN (nonpolarization) condi-
tions for 24 h followed by cytokine stimulation for 2 h. Cells were 
harvested and total RNAs were isolated. The relative expression levels of 
different genes normalized to GAPDH were assessed by real-time PCR 
after reverse transcription. Error bars represent means   ±   SD, and data are 
representative of two independent experiments.     334 RECIPROCAL REGULATIONS BETWEEN GFI-1 AND TGF-       | Zhu et al. 
sequence and an intergenic region of   Il17a/Il17f   near the 
AGAAATCTCAGGG sequence but not the other sites tested 
were enriched by the anti  –  Gfi  -1 antibody in this assay (  Fig. 4 D  , 
left). Consistent with Gfi  -1 binding, this   Il17a/Il17f   inter-
genic region also recruited LSD1 in wild-type cells, and the 
binding of LSD1 to this site was not found in the absence of 
Gfi  -1 (  Fig. 4 D  , right). 
that such sequences may have particularly high binding affi   n-
ity for Gfi  -1 (  51  ). Eight putative Gfi  -1 binding sites contain-
ing AAATCNNNG or its complement CNNNGATTT, 
including the Rorc promoter (Rorcp) from the   Rorc   locus 
and nine sites from the   Il17a/Il17f   loci along with   Gfi  1   pro-
moter (Gfi  1p) as a positive control (  52  ), were tested for Gfi  -1 
binding. Only the Gfi  1p region near the GAAAATCGAAGTA 
    Figure 4.         Gfi  -1 binds to the   Il17a/Il17f   intergenic region and inhibits IL-17a and IL-17f expression.   CD4 +   T cells from naive mice were 
activated under neutral conditions for 24 h and infected with (A  –  C) GFP-RV, (A  –  C) Gfi  -1  –  GFP-RV, (C) or Gfi  -1(P2A)  –  GFP-RV. (A and C) Infected cells 
were further primed under Th17 conditions for 4 d. Cytokine production was assessed by intracellular staining after PMA plus ionomycin stimulation. 
(A) Numbers indicate the percentage of cells in each quadrant (left). Relative IL-17  –  producing cells (GFP  + /GFP      ) pooled from three independent ex-
periments are shown (right). (B) GFP  +   and  GFP       cells were sorted 24 h after infection. Sorted cells were maintained under Th17 conditions for another 
2 d. Cells were harvested and total RNAs were isolated. The expression levels of different genes normalized to GAPDH were assessed by real-time PCR 
after RT. (C) The percentage of IL-17  –  producing cells from each GFP  +   group was plotted. (D) Gfi  -1  –  GFP-RV  –  infected Th17 cells were used for Gfi  -1 
ChIP (left). Wild-type and   Gfi  1   cKO Th2 cells were used for LSD1 ChIP (right). The enrichment of individual sites was normalized to a negative control 
from   Gata3  -intron3. (E) CD4 T cells from naive wild-type or   Gfi  1   cKO mice were primed under Th17 conditions for 4 d. Cytokine production was as-
sessed by intracellular staining after PMA plus ionomycin stimulation. Numbers indicate the percentage of cells in each quadrant (left). Data from 
nine independent experiments are shown (right). Error bars represent means   ±   SD.     JEM VOL. 206, February 16, 2009 
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data), such induction may serve as a negative regulator of 
IL-17 production. 
  Gfi  -1 limits TGF-      –  mediated differentiation of iTreg cells 
in vitro 
  Because Gfi  -1 is also underexpressed in iTreg cells, we tested 
the eff  ect of enforcing Gfi  -1 expression during iTreg cell dif-
ferentiation. Cells primed under iTreg cell conditions were 
infected with Gfi  -1  –  GFP-RV or control GFP-RV. 4 d after 
infection, cells were costained for Foxp3 and IL-2 to identify 
bona fide Treg cells. In the group infected with control 
  When CD4 T cells from   Gfi  1   cKO mice were primed 
under Th17 conditions, a higher percentage of the   Gfi1   
cKO cells than of wild-type cells produced IL-17 (28.4 vs. 
14.5%,   Fig. 4 E  , left). In a series of nine independent ex-
periments, there was a highly statistically significant in-
crease in IL-17  –  producing cells among   Gfi  1   cKO Th17 
cells compared with wild-type Th17 cells (  Fig. 4 E  , right). 
These data indicate that endogenous expression of Gfi  -1 in 
Th17 cells, even at low levels, is suffi   cient to modulate IL-17 
production. Indeed, because Gfi-1 can be induced tran-
siently by TCR stimulation even in Th17 cells (unpublished 
    Figure 5.         Gfi  -1 limits the differentiation of iTreg cells and regulates the CD103  +  Foxp3  +   subset.   (A and B) CD25-depleted CD4  +   T cells were 
activated under neutral conditions for 24 h, infected with RV, and further primed under iTreg cell conditions for 4 d. Cells were restimulated with PMA 
plus ionomycin for 4 h in the presence of monensin during last 2 h. Cytokine production and Foxp3 expression was assessed by intracellular staining. 
(C) CD25-depleted CD4  +   T cells were activated under iTreg cell conditions for 4 d. Cell-surface markers were costained with Foxp3. Dot plots were gated 
on CD4  +   cells. (D) Lymph node cells were stained directly with CD4, Foxp3, and CD103. Dot plots were gated on CD4  +   cells. Numbers indicate the per-
centage of cells in each quadrant (top). Within the CD4  + Foxp3 +   population, the percentage of CD103  +   cells was calculated from the data obtained from 
four mice per group (bottom). (E) Wild-type CD4 T cells that had been primed under Th2 conditions for 4 d were used for Gfi  -1 ChIP (left), and both 
wild-type Th2 and   Gfi  1   cKO Th2 cells were used for LSD1 ChIP (right). Enrichment of individual sites from the   Cd103   locus was normalized to a negative 
control from   Gata3  -intron3. Error bars in B, D, and E represent means   ±   SD.     336 RECIPROCAL REGULATIONS BETWEEN GFI-1 AND TGF-       | Zhu et al. 
approximately twofold increase of IL-17a mRNA in   Gfi  1   cKO 
mice at all time points after MOG immunization (  Fig. 6 B  ). 
Neither IFN-     nor IL-4 mRNA was found to be consistently 
diff  erent from the levels in wild-type mice, possibly because of 
the modest Th1 or Th2 responses of these mice to immuniza-
tion. CD103 mRNA is higher in   Gfi  1   cKO CD4 cells before 
immunization, consistent with the staining data shown in   
Fig. 5 D  , and was further increased after MOG immunization. 
Ex vivo restimulation of CD4 T cells 1 wk after immunization 
followed by anti  –  IL-17 intracellular staining confi  rmed the en-
hancement of IL-17 production in   Gfi  1   cKO mice (  Fig. 6 C  ). 
However, intracellular staining of IL-17  –  producing cells 3 wk 
after immunization revealed no diff  erence between wild-type 
and   Gfi  1   cKO CD4 T cells (unpublished data). The discrep-
ancy between IL-17 mRNA and IL-17 protein at 3 wk after 
immunization may result from the very strong stimulus used 
for restimulation. Nevertheless, the data certainly indicate that 
there was no defect in the generation and expansion of Th17 
cells in   Gfi  1   cKO mice. Flow cytometry analysis showed a 
continuous increase of Foxp3  +   cells in   Gfi  1   cKO mice after 
immunization, which peaked at 3 wk (39.1 and 38.5% in   Gfi  1   
cKO mice compared with 22.8 and 20.5% in wild-type mice; 
  Fig. 6 D  ). Although CD103  +   Treg cells were already high in 
  Gfi  1   cKO mice before immunization, there was a substantial 
increase of such cells after immunization (26.1 and 28.9% in 
  Gfi  1   cKO mice vs. 6% and 3.7% in wild-type mice), suggesting 
that Gfi  -1 normally plays a negative role in the expansion of 
Treg cells in vivo. No apparent lymphocyte infi  ltration into 
the central nervous system (CNS) was found in healthy mice 
from either group after immunization. However, among the 
sick mice, Foxp3  +   cells were more abundant in the CNS of the 
  Gfi  1   cKO mice than of the wild-type mice (Fig. S3 A, available 
at http://www.jem.org/cgi/content/full/jem.20081666/DC1). 
Most Foxp3  +   cells in the CNS were also CD103  +   (Fig. S3 B). 
Thus, Foxp3  +  CD103  +   Treg cells appear to have a dominant 
eff  ect over the IL-17  –  producing cells in   Gfi  1   cKO mice result-
ing in the delay of disease onset. 
    DISCUSSION   
  T cell activation as well as IL-4 stimulation transiently in-
duces Gfi  -1 expression, resulting in optimal Th2 cell expan-
sion (  37  ). In the absence of Gfi  -1, Th2 expansion is aff  ected 
both in vitro and in vivo (  41  ). Th1 cells from   Gfi  1   cKO mice 
expand normally but make more IFN-     than WT Th1 cells. 
In addition,   Gfi  1   cKO Th2 cells display a diff  erent pattern of 
chromatin histone modifi  cation than wild-type Th2 cells. These 
observations led us to reassess the function of Gfi  -1 during 
T cell diff  erentiation, particularly because two new Th lin-
eages, Th17 and iTreg cells, have been recently defi  ned. In 
this paper, we showed that Gfi  -1 is down-regulated by TGF-     
stimulation during Th17 and iTreg cell  –  inducing conditions, 
and enforced expression of Gfi  -1 inhibits both Th17 and iTreg 
cell diff  erentiation. Furthermore, in the absence of Gfi  -1, the 
percentage of Foxp3  +   cells that express CD103 was substan-
tially higher than in wild-type mice, and this subset expanded 
in vivo upon immunization. 
GFP-RV, the majority of both the GFP        and GFP  +   cells 
were Foxp3  +  IL-2        (53.7 and 61.7%;   Fig. 5 A  ).   Although 69.2% 
of GFP        cells from the Gfi  -1  –  GFP-RV  –  infected group were 
Foxp3  +  IL-2       , only 34.9% of GFP  +   cells were Foxp3  +  IL-2       . 
Thus, enforced expression of Gfi  -1 signifi  cantly reduced the 
generation of iTreg cells. Gfi  -1 had a minimal eff  ect on the 
frequency of Foxp3  +   cells induced by TGF-    , but among 
the Foxp3  +   cells, a higher percentage of cells also produced 
IL-2. In a separate experiment, enforced Gfi  -1 expression dur-
ing iTreg cell diff  erentiation enhanced the proportion of IL-2  –
  producing cells from     20 to     35%, whereas Gfi  -1(P2A) 
had no eff  ect (  Fig. 5 B  ), suggesting that the repressive domain 
of the Gfi  -1 is required for its function in regulating iTreg 
cell generation. 
  When naive   Gfi  1   cKO CD4 cells were primed under iTreg 
cell conditions, 25.6% of the cells became Foxp3  +  CD25  hi   cells, 
similar to wild-type cells primed under same conditions (22%; 
  Fig. 5 C  , top). However, 22.5% of the cells from the   Gfi  1   cKO 
culture were also Foxp3  +  CD103  +  , whereas only 12.3% of the 
wild-type cells displayed such a phenotype (  Fig. 5 C  , bottom). 
In addition, 93.3% of the Foxp3  +   cells from the wild-type 
culture were CD62L  hi  , whereas only 63.5% of the Foxp3  +   
  Gfi  1   cKO cells expressed CD62L (unpublished data). The 
more abundant presence of CD103  +  CD62L  lo   cells in the 
  Gfi  1   cKO culture suggests that endogenous Gfi  -1 limits dif-
ferentiation of a population of highly activated Treg cells. In-
deed, ex vivo staining of lymph node cells from wild-type 
and   Gfi  1   cKO mice showed an apparently diff  erent pheno-
type of Treg cells (  Fig. 5 D  ). Although the total percentage 
of Foxp3  +   cells did not diff  er from the wild type to the KO, 
there was a substantial diff  erence in Foxp3  +  CD103  +   cells 
(6.8% in the   Gfi  1   cKO and 2% in the wild type;   Fig. 5 D  , top). 
A more careful analysis showed that     20% of the Foxp3  +   cells 
in wild-type mice were CD103  +  , whereas in   Gfi  1   cKO mice, 
such CD103  +   cells represented     50% of the Foxp3  +   Treg 
cells (  Fig. 5 D  , bottom). Three putative Gfi  -1 binding sites 
containing AAATCACAG from the   Cd103   locus were tested 
for Gfi  -1 binding. The site from   Cd103   intron 1 (near the 
GGAAATCACAGAG sequence), but not the other two 
sites, was enriched by Gfi  -1 antibody by 15  –  20-fold (  Fig. 5 E  , 
left). LSD1 was also recruited to this site in wild-type but 
not   Gfi  -1   cKO cells (  Fig. 5 E  , right). These data suggest that 
CD103 is a direct target of Gfi  -1. 
  Gfi  -1 limits the expansion of Foxp3  +  CD103  +   cells in vivo 
  To address the physiological eff  ects of Gfi  -1 on TGF-      –  medi-
ated responses in vivo, we studied the responses of the cKO 
mice and normal controls to MOG-induced experimental al-
lergic encephalitis (EAE). As expected, 13  –  14 d after MOG 
immunization, wild-type mice began to develop clinical symp-
toms, with a peak in intensity at 3 wk. The onset of disease in 
  Gfi  1   cKO mice was signifi  cantly delayed, by approximately 
1 wk (  Fig. 6 A  ).   IL-17 has been reported as a key player in the 
induction of the disease (  53  ). IL-17a mRNA in CD4 T cells 
was measured by real-time PCR before or after various times 
of immunization without in vitro restimulation. There was an JEM VOL. 206, February 16, 2009 
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binding sites within the   Rorc   or   Il23r   loci, suggesting that they 
may not be the direct targets of Gfi  -1. A future goal will be 
to understand the mechanism through which Gfi  -1 regulates 
the chromatin modifi  cation at the   Rorc   and   Il23r   loci. ROR    t 
is also expressed in the cells cultured under iTreg cell  –  induc-
ing conditions, correlating with the H3K4 methylation in 
such cells, although iTreg cells fail to express IL-17 (unpub-
lished data). These results indicate that ROR    t can be up-
regulated by TGF-     alone (  28  ) and that down-regulation of 
Gfi  -1 by TGF-     is critical for ROR    t expression during 
Th17 cell diff  erentiation. 
  In a model of EAE involving immunization with MOG, the 
percentage of IL-17  –  producing cells found in   Gfi  1   cKO mice 
was modestly higher than in wild-type controls. In addition, 
  Gfi  -1 is a transcriptional repressor (  51  ). Gfi  -1 and its con-
gener Gfi  -1b have been recently reported to associate with the 
histone demethylase LSD1 and CoREST to form a repressive 
complex (  46  ). Gfi  -1 directs the complex to the promoter of 
target genes where LSD1 can demethylate H3K4 residues and 
thus repress transcription. Knockdown of LSD1 in erythroid 
cells leads to increased H3K4 dimethylation and trimethylation 
of Gfi  -1b targets. In this paper, we showed that   Il17a/Il17f   and 
  Cd103   are the targets for Gfi  -1 in T cells. Furthermore, LSD1 
is recruited to those sites in a Gfi  -1  –  dependent manner. 
  The   Rorc   and   Il23r   promoter regions are heavily methyl-
ated on H3K4 residues in   Gfi  1   cKO Th2 cells but not in WT 
Th2 cells; methylation levels are comparable to those found 
in WT Th17 cells. However, we were not able to locate Gfi  -1 
    Figure 6.         Delayed onset of EAE induction in   Gfi  1   cKO mice is correlated with the increased Foxp3  +  CD103  +   population.   (A, left) The time course 
of the disease induction in wild-type and   Gfi  1   cKO mice after MOG immunization. (right) The dates of disease onset after immunization in an individual 
mouse, pooled from three independent experiments, are shown. (B) Splenocytes were harvested at various times after immunization as indicated. CD4 T 
cells were purifi  ed and RNAs were made without in vitro stimulation. The expression of IFN-    , IL-4, IL-17a, and CD103 relative to CD4 was assessed by real-
time PCR. Error bars in A and B represent means   ±   SD. (C) Splenocytes were harvested at day 7 after immunization. Cells were stimulated with platebound 
anti-CD3/anti-CD28 for 6 h with the presence of monensin during the last 2 h before intracellular staining. The dot plots were gated on the CD4  + CD44 hi  
population. (D) Splenocytes harvested from mice 3 wk after immunization were directly stained for CD4, CD103, and Foxp3. The dot plots were gated on 
CD4  +   splenocytes. Numbers indicate the percentage of cells in each quadrant. Data are representative of at least two independent experiments.   338 RECIPROCAL REGULATIONS BETWEEN GFI-1 AND TGF-       | Zhu et al. 
  Given the dual eff  ects of Gfi  -1 on eff  ector and Treg cells, 
modulation of its expression and function could have oppo-
site eff  ects depending on the timing, location, and cell type 
in which it is expressed, just as is the case with the adminis-
tration of TGF-     or anti  –  TGF-     (  57  ). However, blockade 
of Gfi  -1 function during early stages of autoimmune diseases 
may be benefi  cial through the resultant expansion of Treg 
cells. Likewise, the specifi  c targeting of Gfi  -1 in Treg cells 
may enhance their migration to sites of infl  ammation as well 
as increase their suppressive activity. Thus, the predominant 
eff  ect of Gfi  -1 on Treg cells in vivo suggests Gfi  -1 and its 
pathway of action could be considered as a target for modu-
lating Treg cells. 
  MATERIALS AND METHODS 
  Mice.     C57BL/6 mice were obtained from Taconic or the Jackson Labora-
tory.   Gfi  1  fl / fl     -CD4Cre (  41  ) mice have been backcrossed to C57BL/6 mice 
for nine generations. G4 mice have been previously described (  48  ).   Gfi  1  fl / +    -
CD4Cre-G/4 and   Gfi  1  fl / fl     -CD4Cre-G/4 mice were generated by crossing 
  Gfi  1  fl / fl     -CD4Cre to G4 mice. All mice were bred and maintained in a Na-
tional Institute for Allergy and Infectious Diseases (NIAID) specifi  c patho-
gen-free animal facility, and the experiments were performed when mice 
were 8  –  16 wk of age under protocols approved by the NIAID Animal Care 
and Use Committee. 
  Cell culture.     Lymph node CD4 or CD8 T cells were prepared by MACS 
purifi  cation using CD4 or CD8 microbeads (Miltenyi Biotec), and purity was 
usually 90  –  95%. In some experiments, lymph node nonregulatory naive CD4 
T cells were prepared by depleting CD8, B220, IA  b  , CD24, NK1.1, CD16/
CD32, CD11b, and CD25-positive cells using FITC-labeled antibodies 
(BD), followed by anti-FITC microbeads and autoMACS purifi  cation (Mil-
tenyi Biotec). T cell  –  depleted APCs were prepared by incubating spleen cells 
with anti-Thy1.2 and rabbit complement (Cedarlane Laboratories Limited) at 
37  °  C for 45 min, and then irradiating them at 30 Gy (3,000 rad). T cells were 
co-cultured with APCs at a 1:5 ratio in the presence of 1   μ  g/ml anti-CD3 
and 3   μ  g/ml anti-CD28, together with diff  erent combinations of antibodies 
and cytokines: for Th1 conditions, 10   μ  g/ml anti  –  IL-4, 10 ng/ml IL-12, and 
100 U/ml IL-2; for Th2 conditions, 10   μ  g/ml anti  –  IFN-     and 10   μ  g/ml anti  –
  IL-12, 5,000 U/ml IL-4, and 100 U/ml IL-2; for Th17 conditions, 10   μ  g/ml 
anti  –  IL-4, 10   μ  g/ml anti  –  IFN-    , 10   μ  g/ml anti  –  IL-12, 5 ng/ml TGF-    , 
10 ng/ml IL-6, and 10 ng/ml IL-1    ; for iTreg cell conditions, 10   μ  g/ml 
anti  –  IL-4, 10   μ  g/ml anti  –  IFN-    , 10   μ  g/ml anti  –  IL-12, 5 ng/ml TGF-    , and 
100 U/ml IL-2; for ThN (nonpolarization) conditions, 10   μ  g/ml anti  –  IL-4, 
10   μ  g/ml anti  –  IFN-    , 10   μ  g/ml anti  –  IL-12, and 100 U/ml IL-2; and for 
neutral conditions, no exogenous cytokines or antibodies were added. 
  Quantitative RT-PCR.    Total RNA was isolated using TRI zol   (Invitrogen). 
First-strand cDNAs were made using the SuperScript Preamplifi  cation System 
(Invitrogen). Quantitative real-time PCR was performed on a sequence de-
tection system (model 7900HT; Applied Biosystems). The sequences of the 
primers and minor groove binder (MGB) probe for Gfi  -1 are 5    -TGGGCG-
GCGGCTCCTACAAAT-3    , 5    -TGCGGTGTGGAGAACACCTGA-3    , 
and FAM-5    -TGCAGCAAGGTGTT-3    -MGB, respectively. Inventoried 
primer/probe sets for detecting IFN-     (Mm99999071_m1), IL-4 (4312482), IL-
17a (Mm00439619_m1), IL-17f (Mm00521423_m1), Foxp3 (Mm00475156_
m1), Bcl-2 (Mm00477631_m1), Bim (Mm00437795_m1), SOCS-1 
(Mm00782550_s1), CD103 (Mm00434443_m1), CD4 (Mm00442754_m1), 
TGF-    RI (Mm00436971_m1), TGF-    RII (Mm00436978_m1), IL-6R     
(Mm00439653_m1), GAPDH (4308313), and ROR    t (Mm01261022_m1) 
were purchased from Applied Biosystems. 
  Preparation of retroviral constructs and infection.     Gfi  -1  –  GFP-RV 
and Gfi  -1(P2A)  –  GFP-RV were previously constructed (  37  ). Retroviruses 
  Toxoplasma gondii   infection or   Schistosoma mansoni   egg injec-
tion induced higher levels of IL-17 production in   Gfi  1   cKO 
than in wild-type mice (unpublished data). Thus, similar to 
our in vitro results, the optimal appearance of IL-17  –  produc-
ing cells induced by TGF-     in vivo requires down-regula-
tion of Gfi  -1 expression, which is transiently induced by T 
cell activation and/or IL-4 stimulation. 
  Gfi  -1 expression is also down-regulated by TGF-     during 
iTreg cell diff  erentiation, and enforced expression of Gfi  -1 
partially suppresses the induction of Foxp3  +  IL-2        Treg cells. 
By down-regulating Gfi  -1, Treg cells become more active and 
also display a tissue-seeking phenotype. In   Gfi  1   cKO mice, the 
proportion of Foxp3  +  CD103  +   eff  ector/memory Treg cells is 
already high, but this population is further increased after 
MOG immunization. In addition, Foxp3  +  CD103  +   are also ex-
panded during   T. gondii   infection or in response to   S. mansoni   
egg injection (Fig. S4, available at http://www.jem.org/cgi/
content/full/jem.20081666/DC1). We have not yet deter-
mined whether the increased percentage of Foxp3  +  CD103  +   
cells in the   Gfi  1   cKO mice and the expansion of this subset af-
ter immunization refl  ects a unique role for Gfi  -1 in the devel-
opment of Foxp3  +  CD103  +   thymic-derived Foxp3  +   T cells, or 
whether the higher percentage of Foxp3  +  CD103  +   T cells is 
secondary to an increased contribution of peripherally gener-
ated Foxp3  +  CD103  +   in the cKO mice that is further potenti-
ated after immunization. In normal mice, the Foxp3  +  CD103  +   
cell population is actively cycling and contains a high propor-
tion of apoptotic cells (  7  ), so it remains possible that Gfi  -1 may 
play a role in the homeostasis of this subset. 
  A selective eff  ect of Gfi  -1 on Treg cells with a modest 
eff  ect on Th17 cell diff  erentiation in vivo could be explained 
by the diff  erential requirement of TGF-     in the induction of 
these two lineages. A low concentration of TGF-    is suffi   cient 
for Th17 cell diff  erentiation, whereas iTreg cell diff  erentia-
tion requires a higher concentration of TGF-     (  54  ). In the 
absence of Gfi  -1, Treg cell numbers may increase in response 
to levels of TGF-     that normally only induce Th17 cell dif-
ferentiation in wild-type mice after MOG immunization. 
  The selective expansion of the Foxp3  +  CD103  +   cells cor-
relates with delayed EAE onset. Treg cells have been sug-
gested to suppress autoimmune diseases by several mechanisms: 
by suppressing the activation and expansion of the eff  ector 
cells (  6  ); by suppressing functions of eff  ector cells, such as cyto-
kine production (  55  ); and by limiting recruitment of eff  ector 
cells to sites of infl  ammation (  56  ). In our model, the disease 
onset was delayed in the   Gfi  1   cKO mice, yet the number of 
eff  ector cells that are capable of making IL-17 was not only 
not reduced but was modestly increased. Thus, it is most 
likely that the Foxp3  +  CD103  +   cells suppress disease by aff  ect-
ing recruitment and/or activation of the eff  ector cells at in-
fl  ammation sites consistent with the tissue-seeking phenotype 
of the Foxp3  +  CD103  +   T cells that are increased in frequency 
in   Gfi  1   cKO mice. The majority of Treg cells found in the 
CNS are Foxp3  +  CD103  +  , even in wild-type mice. In addition, 
Treg cells are a much larger proportion of CNS CD4 T cells 
in   Gfi  1   cKO than in wild-type mice. JEM VOL. 206, February 16, 2009 
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peptide (MEVGWYRSPFSRVVHLYRNGK) and 400   μ  g of   Mycobacterium 
tuberculosis   strain H37Ra in complete Freund  ’  s adjuvant (Difco). On days 
0 and 2, the mice received an intraperitoneal injection of 200 ng pertussis 
toxin (EMD) dissolved in PBS. Clinical symptoms were assessed by the fol-
lowing criteria: 0, no signs of disease; 1, complete tail paralysis; 2, hind limb 
paresis; 3, complete hind limb paralysis; 4, unilateral forelimb paralysis; and 5, 
moribund/death. Mice observed in a moribund state were killed. Data pre-
sented are the mean clinical scores of fi  ve mice per group. 
  Online supplemental material.     Fig. S1 shows the expression of ROR    t, 
TGF-    RI, TGF-R    RII, and IL-6R     in Th1, Th2, and Th17 cells and in 
Gfi  -1  –  RV  –  infected Th17 cells. Fig. S2 shows the suppression of IL-17 ex-
pression by Gfi  -1 in   Gfi  1   cKO Th17 cells. Fig. S3 shows the frequency and 
the phenotype of Treg cells found in the CNS of the WT and   Gfi  1   cKO mice 
after MOG immunization. Fig. S4 shows the expansion of Foxp3  +  CD103  +   
Treg cells in   Gfi  1   cKO mice during   T. gondii   infection or in response to 
  S. mansoni   egg injection. Online supplemental material is available at http://
www.jem.org/cgi/content/full/jem.20081666/DC1. 
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were packaged in the Phoenix-Eco packaging cell line, as previously de-
scribed (  36  ). Infection was performed at 24 h after the initiation of the cul-
ture in which CD4 T cells were activated with anti-CD3/anti-CD28 under 
neutral conditions in the presence of APCs. 
  Flow cytometry analysis.     The expression of GFP in retrovirally infected 
cells was measured by fl  ow cytometry. Cell-surface staining was performed 
in PBS containing 0.1% PBS with diff   erent combination of antibodies. 
Anti  –  IFN-      –  FITC, anti  –  IL-4  –  PE, anti  –  IL-17a  –  PE, anti-CD25  –  PE, anti-
CD25  –  PerCP  –  Cy5.5, anti-CD4  –  PE  –  Cy5, anti  –  IFN-      –  allophycocyanin, and 
anti-CD44  –  allophycocyanin were purchased from BD. Anti-CD103  –  FITC 
(2E7), anti-CD103  –  PE (2E7), anti-Foxp3  –  PE (FJK-16s), anti-Foxp3  –  allophy-
cocyanin (FJK-16s), anti  –  IL-17a  –  Alexa Fluor 647 (eBio17B7), anti  –  IL-2  –  Pacifi  c 
blue (JES6-5H4), anti-CD62L  –  Pacifi  c blue (MEL-14), anti  –  IFN-      –  PerCP  –
  Cy5.5 (XMG1.2), anti-CD44  –  allophycocyanin  –  Alexa Fluor 750 (IM7), and 
anti-CD4  –  Alexa Fluor 700 (GK1.5) were purchased from eBioscience. For 
intracellular cytokine staining, cells were restimulated with 10 ng/ml PMA and 
1   μ  M ionomycin for 4 h or with platebound anti-CD3 and anti-CD28 (3   μ  g/ml 
each) for 6 h in the presence of 2   μ  M monensin during last 3 h. Harvested 
samples were fi  xed with 4% formaldehyde, washed, and permeabilized in 0.5% 
Triton X-100  –  0.1% BSA in PBS before staining for cytokine production. In-
tracellular staining of Foxp3 was performed according to the instructions of the 
Foxp3 staining kit (eBiosciences). When GFP is present, Foxp3 was stained in 
Triton X-100 buff  er, which is used for staining cytokines. 
  ChIP and histone H3K4 modifi  cation  analysis.     For Gfi  -1  and 
LSD1 ChIP, 5   ×   10  6   CD4  +   T cells that have been cultured under Th2 
or Th17 conditions for 4  –  5 d were cross-linked with formaldehyde treat-
ment, and the chromatin was sonicated into small fragments from     200 
to 1,000 bp. The fragmented chromatin was immunoprecipitated with 
the specifi  c antibody. Anti  –  Gfi  -1 (N-20) was purchased from Santa Cruz 
Biotechnology, Inc. Anti-LSD1 was purchased from Abcam. Precipitated 
DNA fragments were reverse cross-linked, and the enrichment of spe-
cifi  c sites was tested by real-time PCR using SYBR green and the rela-
tive enrichment was normalized to a negative site from Gata3-intron3. The 
primers are as follows: Rorcp, 5    -ATTCCATGAGGGCTTGCCT-3     
and 5    -ACCTGTCA  TC  A    G  CCTCCCATA-3    ; Gfi1p, 5    -CGAAG-
TATTCTTGGCTCCTGGA-3     and 5    -GCCCAAACAGTCGACAG-
GATT-3    ; Il17a/Il17f, 5    -TGCTGGGCAGGAAGATACTC-3     and 
5    -TCCCCACTCTGTC  T  TTCCAG-3    ; Cd103-5    , 5    -CCCACCCGCT-
GTAGACATGT-3     and 5    -CCCAGCCATACCCGAAGAT-3    ; Cd103-
intron1, 5    -CCC  ACCCAA  CACGTC  CTCTAA-3     and 5    -CTCATAT-
C  TTAATCTAAGCACTCAGCGTT-3    ; Cd103-3    , 5    -CCCTGCCT-
GGACTACAAAGTG-3     and 5    -CTGC  CTCCACCTCCCAAGT-3    ; 
and Gata3-intron3, 5    -TCAGGGCACTAAGGGTTGTTAACTT-3     and 
5    -GAATTCCATCCATGAGACACACAA-3    . 
  For ChIP-Seq experiments (  47  ), 10  7   CD4  +   T cells that have been cul-
tured under Th2 or Th17 conditions for 4 d were cross-linked with formalde-
hyde treatment and digested with MNase to generate mainly mononucleosomes 
with a minor fraction of dinucleosomes. ChIP was performed by using anti-
H3K4me3 (Abcam). The ChIP DNA ends were repaired using polynucleo-
tide kinase and Klenow enzyme, followed by treatment with Taq polymerase 
to generate a protruding 3     A base used for adaptor ligation. After ligation of 
a pair of Solexa adaptors to the repaired ends, the ChIP DNA was amplifi  ed 
using the adaptor primers for 17 cycles, and the fragments around 220 bp 
(mononucleosome plus adaptors) were isolated from agarose gel. The purifi  ed 
DNA was used directly for cluster generation and sequencing analysis using 
the Illumina/Solexa 1G Genome Analyzer according to the manufacturer  ’  s 
protocols. Sequence reads were obtained and mapped to the mouse genome 
with the Illumina GA Pipeline. Read positions were adjusted 75 bp to be 
centered on the sequenced chromatin fragments, and the number of adjusted 
reads originating in 200-bp windows were summed and displayed as custom 
tracks on the University of California Santa Cruz Genome Browser. 
  EAE induction.     EAE was induced via subcutaneous immunization into the 
hind fl  ank with 200   μ  l of an emulsion containing 400   μ  g of MOG35-55 340 RECIPROCAL REGULATIONS BETWEEN GFI-1 AND TGF-       | Zhu et al. 
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